Hormone Replacement Therapy Market Trends

  • Report ID: 866
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Hormone Replacement Therapy Market Trends

Growth Drivers

  • Higher Number of Women Hitting Menopause - As of 2020, in the USA, around 50% of women aged 35 or above were facing sleep problems, 45% of them had skin dryness, 30% suffering from depression, and 30% women were living with night sweats due to menopause. Menopause is a time that comes in a women’s life after she has her last menstrual cycle. Menopause is commonly diagnosed after 12 months without having a menstrual period which generally occurs in the 40s or 50s. During this period, women face severe hormonal changes that can affect their daily life. Hence, hormone replacement therapy becomes beneficial to soothe the symptoms of menopause.
  • Growing Cases of Anxiety Disorders - In 2019, around 4% of the global population was estimated to be suffering from anxiety disorders.
  • Spiking Prevalence of Thyroid in Modern Population - For instance, approximately 10 out of 100,000 women and 3 out of 100,000 men are projected to be living with thyroid.
  • Worldwide Proliferation in Hypertension - For instance, approximately 1.50 billion people globally between the ages of 30-79 had hypertension in 2021.
  • Utilization of Hormone Replacement Therapy to Cure Liver Disease - It has been observed that around 1.8 million people die due to liver disease every year across the globe.

Challenges

  • Possibilities of Side-Effects of the Therapy – Hormone replacement therapy is anticipated to cause some problems with digestive system of that person who takes this therapy. A person feels sick, have diarrhea, constipation, and even loss of appetite.
  • Requirement for Higher Initial Investment
  • Lack of Skilled Medical Professionals

Hormone Replacement Therapy Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

7.7%

Base Year Market Size (2024)

USD 37.29 billion

Forecast Year Market Size (2037)

USD 98.63 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 866
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of hormone replacement therapy is evaluated at USD 39.62 billion.

The hormone replacement therapy market size was valued at USD 37.29 billion in 2024 and is expected to reach USD 98.63 billion by the end of 2037, expanding at around 7.7% CAGR during the forecast period i.e., between 2025-2037. Higher number of women hitting menopause and growing cases of anxiety disorders will drive the market growth.

North America industry is anticipated to hold majority revenue share by 2037, propelled by significant growth in the geriatric population along with the significant presence of a well-structured healthcare infrastructure in the region.

The major players in the market include AbbVie Inc., Abbott Laboratories, Novo Nordisk A/S, Genentech, Inc., Novartis AG, F. Hoffmann-La Roche Ltd, Merck KGaA, Mylan N.V., Bayer AG, Eli Lilly and Company.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample